Skip to content
10-K

Annual Report

PRESSURE BIOSCIENCES, INC.

0001493152-24-023201

← back to feed
Filed
Jun 7, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jun 4, 2024 34.71M sh
Shares Diluted FY 2023 · Dec 31, 2023 23.34M sh
Shares Diluted FY 2023 · Dec 31, 2022 11.06M sh
Capex FY 2023 · Dec 31, 2023 $7.5K
Capex FY 2023 · Dec 31, 2022 $20.76K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$3.19M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$4.48M
Cash And Equivalents FY 2023 · Dec 31, 2023 $81.28K
Cash And Equivalents FY 2023 · Dec 31, 2022 $3.87K
Stockholders Equity FY 2023 · Dec 31, 2023 −$32.75M
Stockholders Equity FY 2023 · Dec 31, 2022 −$32.69M
Stockholders Equity FY 2023 · Dec 31, 2021 −$22.21M
Current Liabilities FY 2023 · Dec 31, 2023 $33.58M
Current Liabilities FY 2023 · Dec 31, 2022 $34.4M
Total Liabilities FY 2023 · Dec 31, 2023 $33.8M
Total Liabilities FY 2023 · Dec 31, 2022 $34.7M
Current Assets FY 2023 · Dec 31, 2023 $760.06K
Current Assets FY 2023 · Dec 31, 2022 $1.24M
Total Assets FY 2023 · Dec 31, 2023 $1.05M
Total Assets FY 2023 · Dec 31, 2022 $2.01M
Eps Diluted FY 2023 · Dec 31, 2023 −$1.51
Eps Diluted FY 2023 · Dec 31, 2022 −$1.61
Eps Basic FY 2023 · Dec 31, 2023 −$1.51
Eps Basic FY 2023 · Dec 31, 2022 −$1.61
Sga Expense FY 2023 · Dec 31, 2023 $8.21M
Sga Expense FY 2023 · Dec 31, 2022 $3.24M
Rd Expense FY 2023 · Dec 31, 2023 $1.37M
Rd Expense FY 2023 · Dec 31, 2022 $969.53K
Net Income FY 2023 · Dec 31, 2023 −$29.31M
Net Income FY 2023 · Dec 31, 2022 −$16.08M
Operating Income FY 2023 · Dec 31, 2023 −$9.5M
Operating Income FY 2023 · Dec 31, 2022 −$4.9M
Operating Income restated FY 2023 · Dec 31, 2017 $91.02M
Cost Of Revenue FY 2023 · Dec 31, 2023 $1.18M
Cost Of Revenue FY 2023 · Dec 31, 2022 $2.01M
Revenue FY 2023 · Dec 31, 2023 $1.98M
Revenue FY 2023 · Dec 31, 2022 $1.73M